banner
Reference Listed Drugs
Afinitor 2.5mg 5mg 10mg Everolimus Tablets Reference Listed Drug

Afinitor 2.5mg 5mg 10mg Everolimus Tablets Reference Listed Drug

Afinitor is used for the treatment of patients with advanced renal cell carcinoma after treatment failure of sunitinib or sorafenib. For R&D purposes only.

Product Details

* Please be kindly noted products are supplied for RLD supplies/ Reference listed drugs/ Comparator Drug Clinical trials. We do not sell to patients.

 

Generic name Everolimus Tablets
Trade name Afinitor
Specification

2.5mg

5mg

10mg

Main ingredients Everolimus
Appearance This product is white or yellowish tablet.
MA Holder Novartis Pharma Schweiz AG
Manufacturer Novartis Pharma Stein AG
Indications

1.Treatment of patients with advanced renal cell carcinoma after treatment failure of sunitinib or sorafenib.


2.Patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis (TS)who require therapeutic intervention but are not candidates for surgical resection. SEGA volume change was used to analyze the effectiveness of AFINITOR. No clinical benefit such as disease-related symptom improvement or increase in overall survival has been shown.

 

 

 

Afinitor-1

 

Afinitor-2

 

 

 

For more details,pls contact Janney:

Email: tosun-global@upharm.cn

Wechat/Whatsapp:(+86)18922120575

 

 

 

Hot Tags: Afinitor 2.5mg 5mg 10mg Everolimus Tablets Reference Listed Drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Acarbose Tablets, AdapaleneGel, Alfacalcidol Soft Capsules, Adefovir Dipivoxil Tablets, Olanzapine Tablets, Agomelatine Tablets

Send Inquiry
Verification Code: